JAMES P. TURSI
Dr. James P. Tursi is the Executive Vice President of Global Research and Development for Endo Pharmaceuticals. He is responsible for leading strategy and driving execution across Endo’s three business pillars: Branded Pharmaceuticals, Sterile Injectables and durable Generic Pharmaceuticals.
Prior to joining industry, Dr. Tursi practiced medicine and surgery for over 10 years and created I Will Pass®, a medical education company which assisted physicians with board certification. In pharma, he has 20 years of R&D and commercialization experience specializing in urology, orthopedics, microbiome, women’s health, men’s health, plastic surgery / cosmetic medicine and drug-device applications.
He began his industry career holding roles of increasing responsibility at Procter & Gamble Pharmaceuticals and GlaxoSmithKline Biologicals followed by Chief Medical Officer (CMO) roles in innovative biopharmaceutical companies. Just prior to Endo, James was Chief Scientific Officer of Ferring Pharmaceuticals U.S.
During his tenure as CMO, Dr. Tursi and his team’s successful initiation and execution of several development programs through all phases of development has resulted in multiple FDA approvals, initiated device innovation efforts and he's work was supportive of the $2.6 billion acquisition of Auxilium Pharmaceuticals by Endo Pharmaceuticals and the $960 million acquisition of Antares Pharma by Halozyme Therapeutics.
Dr. Tursi holds a Bachelor of Science in Chemistry and Biology from Ursinus College, a Doctor of Medicine from the Medical College of Pennsylvania and completed his residency in Gynecology and Obstetrics at the Johns Hopkins Hospital.
Dr. Tursi is also currently a member of the Ideal Image (www.Idealimage.com) Board of Directors.